March 8, 2022 – Cardinal Health Specialty Solutions launched Decision Path, the newest addition to the Navista™ Tech Solutions (TS) suite of technology solutions, created to help oncology practices lower costs, improve patient care and drive success in transitioning to value-based care.
According to the National Cancer Institute, cancer is one of the most expensive medical conditions to treat in the United States; its treatment can cause great financial distress – often called financial toxicity – for some cancer patients and their families.
Developed by Fuse, Cardinal Health’s innovation engine, Decision Path is a first of its kind solution to be built into the electronic health record (EHR) workflow, allowing oncologists to easily compare cancer treatment options, both by clinical indication and cost, at the point of care. Prior to Decision Path, many systems provided cost data outside of the EHR, requiring more time and effort for the physician and care team to locate the necessary information.
More than 2,000 cancer protocols currently are approved by the National Comprehensive Cancer Network and new therapies are rapidly emerging, making it a growing challenge for physicians to quickly and accurately evaluate which treatment option will deliver the best clinical outcome for each patient at the lowest cost. Prices and payer coverage for cancer therapies can vary widely, and, until now, physicians generally did not have easy visibility into treatment costs until after the prescription was written and the patient was on therapy.
In addition to Decision Path, Navista™ TS is an integrated suite of tech solutions that empowers community oncology practices to improve patient care and gain financial strength in multiple ways.